These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36626635)

  • 21. Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD.
    Sabino J; Vieira-Silva S; Machiels K; Joossens M; Falony G; Ballet V; Ferrante M; Van Assche G; Van der Merwe S; Vermeire S; Raes J
    Gut; 2016 Oct; 65(10):1681-9. PubMed ID: 27207975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut microbiota-mediated liver inflammation in PSC.
    Dickson I
    Nat Rev Gastroenterol Hepatol; 2019 Mar; 16(3):140-141. PubMed ID: 30705395
    [No Abstract]   [Full Text] [Related]  

  • 23. Alterations of the bile microbiome in primary sclerosing cholangitis.
    Liwinski T; Zenouzi R; John C; Ehlken H; Rühlemann MC; Bang C; Groth S; Lieb W; Kantowski M; Andersen N; Schachschal G; Karlsen TH; Hov JR; Rösch T; Lohse AW; Heeren J; Franke A; Schramm C
    Gut; 2020 Apr; 69(4):665-672. PubMed ID: 31243055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis.
    Bajer L; Kverka M; Kostovcik M; Macinga P; Dvorak J; Stehlikova Z; Brezina J; Wohl P; Spicak J; Drastich P
    World J Gastroenterol; 2017 Jul; 23(25):4548-4558. PubMed ID: 28740343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PSC associated inflammatory bowel disease: a distinct entity.
    Beheshti-Maal A; Tamimi A; Iravani S; Memarnejadian A; Sorouri M; Aghdaei HA; Zali MR; Hossein Khannazer N; Vosough M
    Expert Rev Gastroenterol Hepatol; 2022 Feb; 16(2):129-139. PubMed ID: 35078376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis.
    Kevans D; Tyler AD; Holm K; Jørgensen KK; Vatn MH; Karlsen TH; Kaplan GG; Eksteen B; Gevers D; Hov JR; Silverberg MS
    J Crohns Colitis; 2016 Mar; 10(3):330-7. PubMed ID: 26526357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The features of mucosa-associated microbiota in primary sclerosing cholangitis.
    Torres J; Bao X; Goel A; Colombel JF; Pekow J; Jabri B; Williams KM; Castillo A; Odin JA; Meckel K; Fasihuddin F; Peter I; Itzkowitz S; Hu J
    Aliment Pharmacol Ther; 2016 Apr; 43(7):790-801. PubMed ID: 26857969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of intestinal flora in primary sclerosing cholangitis and its potential therapeutic value.
    Li ZJ; Gou HZ; Zhang YL; Song XJ; Zhang L
    World J Gastroenterol; 2022 Nov; 28(44):6213-6229. PubMed ID: 36504550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut Microbiome of Children and Adolescents With Primary Sclerosing Cholangitis in Association With Ulcerative Colitis.
    Cortez RV; Moreira LN; Padilha M; Bibas MD; Toma RK; Porta G; Taddei CR
    Front Immunol; 2020; 11():598152. PubMed ID: 33613519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis.
    Kummen M; Thingholm LB; Rühlemann MC; Holm K; Hansen SH; Moitinho-Silva L; Liwinski T; Zenouzi R; Storm-Larsen C; Midttun Ø; McCann A; Ueland PM; Høivik ML; Vesterhus M; Trøseid M; Laudes M; Lieb W; Karlsen TH; Bang C; Schramm C; Franke A; Hov JR
    Gastroenterology; 2021 Apr; 160(5):1784-1798.e0. PubMed ID: 33387530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Editorial: gut microbial profile associated with primary sclerosing cholangitis-what is new and how do we progress from here?
    Quraishi MN; Shaheen WA
    Aliment Pharmacol Ther; 2019 Sep; 50(5):605-606. PubMed ID: 31414544
    [No Abstract]   [Full Text] [Related]  

  • 32. Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis.
    Nakamoto N; Sasaki N; Aoki R; Miyamoto K; Suda W; Teratani T; Suzuki T; Koda Y; Chu PS; Taniki N; Yamaguchi A; Kanamori M; Kamada N; Hattori M; Ashida H; Sakamoto M; Atarashi K; Narushima S; Yoshimura A; Honda K; Sato T; Kanai T
    Nat Microbiol; 2019 Mar; 4(3):492-503. PubMed ID: 30643240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis.
    Liao L; Schneider KM; Galvez EJC; Frissen M; Marschall HU; Su H; Hatting M; Wahlström A; Haybaeck J; Puchas P; Mohs A; Peng J; Bergheim I; Nier A; Hennings J; Reißing J; Zimmermann HW; Longerich T; Strowig T; Liedtke C; Cubero FJ; Trautwein C
    Gut; 2019 Aug; 68(8):1477-1492. PubMed ID: 30872395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Editorial: gut microbial profile associated with primary sclerosing cholangitis-what is new and how do we progress from here? Authors' reply.
    Rühlemann M; Franke A
    Aliment Pharmacol Ther; 2019 Sep; 50(5):606-607. PubMed ID: 31414547
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of gut microbiota in primary biliary cholangitis.
    Jin WM; Song SY; Xu XF; Wen CP; Hu CF
    Hepatobiliary Pancreat Dis Int; 2022 Dec; 21(6):597-599. PubMed ID: 35780017
    [No Abstract]   [Full Text] [Related]  

  • 36. Gut microbiota depletion exacerbates cholestatic liver injury via loss of FXR signalling.
    Schneider KM; Candels LS; Hov JR; Myllys M; Hassan R; Schneider CV; Wahlström A; Mohs A; Zühlke S; Liao L; Elfers C; Kilic K; Henricsson M; Molinaro A; Hatting M; Zaza A; Drasdo D; Frissen M; Devlin AS; Gálvez EJC; Strowig T; Karlsen TH; Hengstler JG; Marschall HU; Ghallab A; Trautwein C
    Nat Metab; 2021 Sep; 3(9):1228-1241. PubMed ID: 34552267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances and controversies in the pathogenesis and management of primary sclerosing cholangitis.
    Eksteen B
    Br Med Bull; 2014 Jun; 110(1):89-98. PubMed ID: 24795363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The gut microbial influence on cholestatic liver disease.
    Kummen M; Hov JR
    Liver Int; 2019 Jul; 39(7):1186-1196. PubMed ID: 31125502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis.
    Vesterhus M; Holm A; Hov JR; Nygård S; Schrumpf E; Melum E; Thorbjørnsen LW; Paulsen V; Lundin K; Dale I; Gilja OH; Zweers SJLB; Vatn M; Schaap FG; Jansen PLM; Ueland T; Røsjø H; Moum B; Ponsioen CY; Boberg KM; Färkkilä M; Karlsen TH; Lund-Johansen F
    J Hepatol; 2017 Jun; 66(6):1214-1222. PubMed ID: 28161472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Role of the Intestine in the Pathogenesis of Primary Sclerosing Cholangitis: Evidence and Therapeutic Implications.
    Dean G; Hanauer S; Levitsky J
    Hepatology; 2020 Sep; 72(3):1127-1138. PubMed ID: 32394535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.